The term Synedica Retatrutide is not a recognized international non-proprietary name (INN) nor is it a registered pharmaceutical brand
When patients experience itching during GLP-1 therapy, the cause is often unrelated to the medication itself
as a continuous variable), female gender (1.48), Asian (1.25) or African origin (1.29), diabetes (1.27), obesity (1.31), hypothyroidism (1.38), chronic liver (1.24) or kidney disease (1.25), alcohol consumption (1.22), exercise (1.23), the use of antiarrhythmic agents (1.31), calcium channel blockers (1.36) or statins, primarily at high doses (1.38) [411]
Healthy lifestyle and cancer risk: modifiable risk factors to prevent cancer
These effects diminish as your body adapts over 1-2 weeks and are usually manageable with dietary adjustments